First gene therapy to treat rare blood disease nears European approval

First gene therapy to treat rare blood disease nears European approval

By ADAM FEUERSTEIN

RUBY WALLAU FOR STAT

There are dozens of biotech and pharma companies developing gene therapies for rare diseases today, but Bluebird was an early pioneer.

READ MORE